Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib with Docetaxel/Prednisone in Prostate Cancer
NCT00879619Phase 2Terminated
- Start
- Jul 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in prostate cancer (PCa). Started Jul 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00879619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879619.